Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2008
10/30/2008US20080269126 Albumin Fusion Proteins
10/30/2008US20080269125 Albumin Fusion Proteins
10/30/2008US20080269122 Monoclonal antibody fusion comprising cathelicidin which targets microorganiams for destruction; for use in health care, veterinary medicine and food processing
10/30/2008US20080269115 Immunogenic Sars Domain
10/30/2008US20080268536 Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
10/30/2008US20080268072 Method of Improving Anticancer Effect of Pulsatillae Radix and a Composition Prepared by the Method
10/30/2008US20080268033 Biologically active methylene blue derivatives
10/30/2008US20080268027 Oral administering a drug; drying self-supporting polymer film and drug dosage
10/30/2008US20080268022 Mehtods for treating and preventing ailments caused by human papillomavirus
10/30/2008US20080268010 Inhibiting growth of bacteria on implantable medical devices
10/30/2008US20080267998 Combinations of gene deletions for live attenuated shigella vaccine strains
10/30/2008US20080267996 Compositions for inducing an immune response against hepatitis B
10/30/2008US20080267995 Administering a recombinantly produced protein encoded by one of the open reading frames in the porcine circovirus type 2 antigen genome
10/30/2008US20080267993 Administering Human Immunodeficiency Virus type 1 Envelope (env) sequence having a first set of consensus glycosylation sequences, followed by a second immunogen comprising a primate immunodeficiency virus env sequence having a second set of consensus glycosylation sequences
10/30/2008US20080267992 Sars Virus Vaccine with Adenovirus Carrier and Preparation Method Thereof, and Use of Sars Virus S Gene for Preparation of Vaccine
10/30/2008US20080267990 Nucleotide sequences coding interferon inducer for use in detection of mycobacterial infection
10/30/2008US20080267980 Complement Receptor 2 Targeted Complement Modulators
10/30/2008US20080267975 Using lymphocyte profiles comprising aberrant transmembrane receptor tyrosine kinase (Mer) expression as evaluative tool in screening for blood clotting and/or cell proliferative disorders
10/30/2008US20080267964 Synergistic Effect of Tgf-Beta Blockade and Immunogenic Agents on Tumors
10/30/2008US20080267962 Albumin Fusion Proteins
10/30/2008US20080267961 SOLUBLE ErbB3 AND TREATMENT OF CANCER
10/30/2008US20080267955 Frizzled 9 as tumor marker
10/30/2008US20080267943 Innate Immune Receptor Directed Biocides
10/30/2008US20080267918 Serine protease inhibitors; replication inhibition
10/30/2008US20080267917 N-functionalized amides as hepatitis c serine protease inhibitors
10/30/2008US20080267916 Cyclic p3 tripeptide hepatitis c serine protease inhibitors
10/30/2008US20080267914 Chemical Compounds
10/30/2008US20080267912 Novel inhibitors of glutaminyl cyclase
10/30/2008US20080267906 Novel Spirotropane Compounds and Methods for the Modulation of Chemokine Receptor Activity
10/30/2008US20080267875 Androgens conjugated with mammalian proteins; diagnosis or treatment of solid cancer and hematological malignancies; exhibit synergistic action together with a cytoskeleton-acting drug; prostate cancer
10/30/2008DE102007020152A1 Mittel zur antiinfektiven Behandlung eines Patienten Anti-infective agent for treatment of a patient
10/30/2008CA2721739A1 Drug combination and its use in the treatment of muscle loss
10/30/2008CA2685153A1 Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
10/30/2008CA2684659A1 Tricyclic nitrogen containing compounds as antibacterial agents
10/30/2008CA2684360A1 Use of fungicides for the treatment of fish mycoses
10/30/2008CA2684342A1 Use of fungicides for the treatment of fish mycoses
10/30/2008CA2684240A1 Tetrahydroindole and tetrahydroindazole derivatives
10/30/2008CA2683958A1 Topical fungicidal agents for treating nail disorders
10/30/2008CA2681500A1 Antibacterial compositions comprising an extract from arceuthobium
10/30/2008CA2678004A1 Utilisation de lactobacillus casei pour renforcer la protection induite par la vaccination anti-grippale
10/29/2008EP1986011A2 Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
10/29/2008EP1985706A2 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins
10/29/2008EP1985705A2 Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections
10/29/2008EP1985699A1 Controlled dissolution crosslinked protein crystals
10/29/2008EP1985632A2 Use of VEGF2 antibodies for inhibiting photoreceptor cell proliferation
10/29/2008EP1985626A1 P. gingivalis antigenic composition
10/29/2008EP1985625A2 Synthetic peptide constructs for the diagnosis and treatment of periodontitus associated with porphyromonas gingivalis
10/29/2008EP1985620A1 10a-AZALIDE COMPOUND
10/29/2008EP1985309A1 Nanoparticle containing water-soluble non-peptidic low molecular weight substance
10/29/2008EP1985308A2 Water-soluble compositions of bioactive lipophilic compounds
10/29/2008EP1985301A1 Method of inducing cytotoxic t-cell, cytotoxic t-cell inducer and, produced therewith, pharmaceutical composition and vaccine
10/29/2008EP1985291A2 Endodontic fibers and methods of use therefor
10/29/2008EP1984379A2 Anti-arenaviral compounds
10/29/2008EP1984376A2 Chemical compounds
10/29/2008EP1984369A2 Nitroimidazole compounds
10/29/2008EP1984364A1 Heterobicyclic amide derivatives
10/29/2008EP1984332A2 Methods for treating hepatitis c
10/29/2008EP1984323A1 Viral polymerase inhibitors
10/29/2008EP1749011B1 Bicyclic heterocycles as hiv integrase inhibitors
10/29/2008EP1653914A4 Oxime substituted imidazo-containing compounds
10/29/2008EP1648889B1 Isethionate salt of a selective cdk4 inhibitor
10/29/2008EP1556141B1 Method for the prophylaxis and therapy of mycoses in fish and invertebrates and the development stages thereof
10/29/2008EP1506195B1 Non-nucleoside reverse transcriptase inhibitors
10/29/2008EP1474067B1 One dose vaccination with i mycoplasma hyopneumoniae /i
10/29/2008EP1406650B1 Use of poly-glu, tyr for neuroprotection therapy of the cns or pns
10/29/2008EP1370697B1 Peroxiredoxin drugs for treatment of hiv-1 infection
10/29/2008EP1317256B1 Pharmaceutical composition having modified carrier
10/29/2008EP1297145B1 Streptococcus pyogenes antigen
10/29/2008EP1294771B1 Chimeric GapC protein from Streptococcus and its use in vaccination and diagnosis
10/29/2008EP1278868B9 Mutated form of arginine deiminase
10/29/2008EP1265608B1 Oxazolidinone tablet formulation
10/29/2008EP1255560B1 Cd40 ligand adjuvant for respiratory syncytial virus vaccine
10/29/2008EP1234044B1 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides
10/29/2008EP1196607B1 Chlamysin b antibacterial protein, gene encoding it and an expression system for it
10/29/2008EP1180155B1 Vector for integration of heterologous sequences into poxviral genomes
10/29/2008EP0846128B1 Antimicrobial cationic peptides and methods of screening for the same
10/29/2008EP0831912B2 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
10/29/2008EP0752872B1 Nadh oxidase as a target in diagnosis and therapy
10/29/2008EP0610250B2 Porcine reproductive respiratory syndrome (prrs) vaccine and diagnostic
10/29/2008CN101296926A Heterocyclic aspartyl protease inhibitors
10/29/2008CN101296689A Micronised azodicarbonamide, the preparation and use thereof
10/29/2008CN101294159A Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of hiv infection
10/29/2008CN101294144A Type II streptococcus suis sa1KR gene knockout mutant strain, preparation method and application thereof
10/29/2008CN101293931A Anti-shrimp white spot syndrome virus recombined bacterium typhosum strain, preparation and uses thereof
10/29/2008CN101293930A Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of hiv infection
10/29/2008CN101293929A Preparation and application of natural polypeptide medicaments derivative
10/29/2008CN101293928A Preparation and application of genetic engineering synthetic polypeptide medicaments for treating tubercle bacillus infection contamination
10/29/2008CN101293927A Preparation and application of artificial synthetic polypeptide medicaments for treating tubercle bacillus infection contamination
10/29/2008CN101293926A Preparation and application of antimicrobial peptide medicaments for treating tubercle bacillus infection contamination
10/29/2008CN101293925A Preparation and application of synthetic polypeptide medicaments for treating tubercle bacillus infection contamination
10/29/2008CN101293922A Streptococcus pneumoniae proteins and nucleic acid molecules
10/29/2008CN101293915A Method for preparing anti-duck plague transfer factor
10/29/2008CN101293914A Method for preparing avian infectiousness bursa of fabricius virus transfer resistant factor
10/29/2008CN101293913A Method for preparing avian infectious brunchitis virus transfer resistant factor
10/29/2008CN101293905A Benzoxazole ketone glycoside compounds and preparation method thereof
10/29/2008CN101293899A Acyclic nucleoside phosphonate derivative and medicine use thereof
10/29/2008CN101293886A Preparing method and application of white banksia rose endogenetic epiphyte product of snail optical black shell bacterium ketone A
10/29/2008CN101293876A Benzoxazole ketones derivative and preparation method thereof
10/29/2008CN101293836A 1-oxygen-substituted benzene formyl quinic acid pharmaceutical use of inhibiting hepatitis B virus
10/29/2008CN101293834A 3,4-di-oxygen-[3-substituted alkene propionyl]quinic acid compounds and medicine uses thereof
1 ... 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 ... 1798